Implantable Cardioverter-Defibrillator Programming: It Is Time to Get Things Right With a Checklist Manifesto.
作者信息
Savona Salvatore, Weiss Raul
机构信息
The Ohio State Wexner Medical Center Columbus OH USA.
Mount Sinai Medical Center Miami Beach FL USA.
出版信息
J Am Heart Assoc. 2024 Aug 6;13(15):e036211. doi: 10.1161/JAHA.124.036211. Epub 2024 Jul 16.
Abstract
摘要
相似文献
1
Implantable Cardioverter-Defibrillator Programming: It Is Time to Get Things Right With a Checklist Manifesto.植入式心脏复律除颤器编程：是时候借助清单宣言把事情做好了。
J Am Heart Assoc. 2024 Aug 6;13(15):e036211. doi: 10.1161/JAHA.124.036211. Epub 2024 Jul 16.
2
Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.旨在减少不必要的植入式心脏复律除颤器治疗的编程策略对死亡率的影响：系统评价和荟萃分析。
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):164-70. doi: 10.1161/CIRCEP.113.001217. Epub 2014 Jan 20.
3
Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.前瞻性随机评估左心室辅助装置患者植入式心脏复律除颤器的程控。
J Am Heart Assoc. 2018 Feb 23;7(5):e007748. doi: 10.1161/JAHA.117.007748.
4
Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).多中心自动除颤器植入试验-降低不适当治疗（MADIT-RIT）中与植入式心脏复律除颤器编程相关的死亡率。
Circ Arrhythm Electrophysiol. 2014 Oct;7(5):785-92. doi: 10.1161/CIRCEP.114.001623. Epub 2014 Aug 18.
5
Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.单腔植入式心脏复律除颤器与双腔植入式心脏复律除颤器比较：少即是多！来自德国器械注册登记处的数据。
Clin Res Cardiol. 2020 Jul;109(7):911-917. doi: 10.1007/s00392-019-01584-x. Epub 2019 Dec 10.
6
Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry.预测因素与休克还原编程及其对植入式心脏转复除颤器治疗和死亡率的影响：CERTITUDE 注册研究。
J Am Heart Assoc. 2024 Aug 6;13(15):e034500. doi: 10.1161/JAHA.124.034500. Epub 2024 Jul 16.
7
Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.在一级预防患者人群中，采用策略性植入式心脏复律除颤器程控以降低电击治疗负担的安全性和有效性。
Europace. 2014 Feb;16(2):227-34. doi: 10.1093/europace/eut302. Epub 2013 Oct 9.
8
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial.皮下或经静脉植入式心律转复除颤器患者的生活质量：PRAETORIAN 试验的二次分析。
Circ Cardiovasc Qual Outcomes. 2024 Nov;17(11):e010822. doi: 10.1161/CIRCOUTCOMES.124.010822. Epub 2024 Nov 19.
9
Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.因T波过度感知导致的不适当皮下植入式心律转复除颤器电击可被预防：对管理的启示
Heart Rhythm. 2014 Mar;11(3):426-34. doi: 10.1016/j.hrthm.2013.12.007. Epub 2013 Dec 7.
10
Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.由于除颤器导线端子在设备插头端口连接不良导致植入式心律转复除颤器（ICD）的除颤阈值无法确定以及电击无效。
Europace. 2007 Dec;9(12):1161-2. doi: 10.1093/europace/eum182. Epub 2007 Oct 3.
本文引用的文献
1
Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry.预测因素与休克还原编程及其对植入式心脏转复除颤器治疗和死亡率的影响：CERTITUDE 注册研究。
J Am Heart Assoc. 2024 Aug 6;13(15):e034500. doi: 10.1161/JAHA.124.034500. Epub 2024 Jul 16.
2
Trends in implantable cardioverter-defibrillator programming practices and its impact on therapies: Insights from a North American Remote Monitoring Registry 2007-2018.2007-2018 年北美远程监测登记研究：植入式心脏复律除颤器程控实践的变化趋势及其对治疗的影响。
Heart Rhythm. 2022 Feb;19(2):219-225. doi: 10.1016/j.hrthm.2021.10.010. Epub 2021 Oct 15.
3
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.2019 年 HRS/EHRA/APHRS/LAHRS 对 2015 年最佳植入式心脏复律除颤器编程和测试专家共识声明的重点更新。
Europace. 2019 Sep 1;21(9):1442-1443. doi: 10.1093/europace/euz065.
4
How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter-Defibrillator Programming Diffuse Into Clinical Practice?.随机临床试验结果和/或植入式心脏复律除颤器编程推荐在多大程度上普及到临床实践中？
J Am Heart Assoc. 2019 Feb 5;8(3):e007392. doi: 10.1161/JAHA.117.007392.
5
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.2015年心律学会（HRS）/欧洲心律协会（EHRA）/亚太心律学会（APHRS）/拉丁美洲心律学会（SOLAECE）关于植入式心脏复律除颤器最佳程控与测试的专家共识声明
Europace. 2016 Feb;18(2):159-83. doi: 10.1093/europace/euv411. Epub 2015 Nov 19.
6
Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.长检测间隔与标准检测间隔对植入式心脏复律除颤器抗心动过速起搏和电击治疗效果的影响：ADVANCE III 随机临床试验。
JAMA. 2013 May 8;309(18):1903-11. doi: 10.1001/jama.2013.4598.
7
Reduction in inappropriate therapy and mortality through ICD programming.通过 ICD 编程减少不适当的治疗和死亡率。
N Engl J Med. 2012 Dec 13;367(24):2275-83. doi: 10.1056/NEJMoa1211107. Epub 2012 Nov 6.
8
Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.植入式心脏复律除颤器检测与治疗参数的策略性编程可减少一级预防患者的电击次数：PREPARE（一级预防参数评估）研究结果
J Am Coll Cardiol. 2008 Aug 12;52(7):541-50. doi: 10.1016/j.jacc.2008.05.011.
Zotero 插件